Alectinib Designed for Dummies

He has been an advisor/consultant to the Panamerican Health Organization, Astellas Pharma, Gilead Sciences, Merck Sharp and Dohme, Pfizer and Schering Plough. He has been paid for talks on behalf of Gilead Sciences, Merck Sharp and Dohme, Pfizer, Astellas Pharma and Schering Plough. J.P.D. has received grant support from, Astellas, Gilead Sciences, Merck Sharp and Dohme, Pfizer and Schering Plough. He has been a consultant or on an advisory board for Astellas, Gilead Sciences, Merck Sharp and Dohme and Pfizer. He has received remuneration for giving lectures on behalf of Gilead Sciences, Merck and Pfizer. J.G. has nothing to declare. A.H.G. has received research support from Gilead, Merck and Schering. He has acted as speaker PI3K inhibitor and/or consultant for Astellas, Cephalon, Gilead, Merck, Pfizer, Schering and Vicuron. R.H. has been a consultant or at the advisory board for Astellas pharma, Basilea, Gilead Sciences, Merck Sharp and Dohme, Novartis, Pfizer?and Schering Plough. He has also received investigator fees for a clinical trial for Pfizer and travel support from Pfizer and Alectinib Gilead. He has received grant support and/or has been paid for talks on behalf of Astellas, Gilead Sciences, Merck Sharp and Dohme, Pfizer, and Schering Plough. W.W.H. has received grant support from National Institute of Health Research (NIHR), Medical Research Council, National Institute for the Replacement, Refinement and Reduction, of Animals in Research, Pfizer, Gilead, Schering Plough, Merck and Astellas, and has served as a consultant for Pfizer, Astellas, Gilead, F2G, Vectura, and Schering Plough. H.E.J. has nothing to declare. B.J.K. has received research grants from Bio-M��rieux and Cephalon. He is a consultant to Pfizer and is Tryptophan synthase a member of the Gilead, MSD and Pfizer speaker bureaus. C.L.-F. has received grant support in the past 5?years from Astellas Pharma, Gilead Sciences, Pfizer, Schering Plough and Merck Sharp and Dohme. She has been an advisor/consultant to Gilead Sciences, Merck Sharp and Dohme, Pfizer, Astellas Pharma and Schering Plough. She has received travel support from and/or been paid for talks on behalf of Gilead Sciences, Merck Sharp and Dohme, Pfizer, Astellas Pharma and Schering Plough. W.M. has received grant support from MSD and Pfizer. He had been an advisor to MSD and Pfizer. He has received honoraria for presentations on behalf of MSD/Schering Plough and Pfizer. M.D.R. has received grants, speaker��s honoraria and travel support from ESCMID, Pfizer, Astellas, MSD and Gilead Sciences. He has also received royalties from Blackwell Publishing. E.R. has received research support from Pfizer, Gilead, Enzon, Schering, Merck and he has made contributions in advisory boards of Gilead, Astellas, Schering, Merck, Pfizer.